Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 1, 2015

View Archived Issues

Genentech's LGR5-targeting ADC inhibits growth of colon cancer

SMRX-11: A clot-specific streptokinase

Novel CSF-1R inhibitor shows promising results for bone tumors

Italian and U.S. academic team patents ASAH1 inhibitors

AbbVie patents V1bR ligands

Chengdu Bestchiralbio announces DPP IV inhibitors

Roche reports anti-HBV agents

Eisai presents splicing factor 3B modulators

Calitor Sciences and Sunshine Lake Pharma present PI3K inhibitors

European Comission approves Horizon's Ravicti

Managed access program for ixazomib begins for patients with multiple myeloma

Heptares enters strategic drug discovery collaboration with Pfizer

Vericiguat holds promise for heart failure

Applications seeking approval of Stelara for Crohn's disease submitted by Janssen

Dose expansion implemented in study of immunomodulator EF-022 in patients with solid tumors

Phase I study of Intercept's INT-767 begins

FDA approves Empliciti for previously treated multiple myeloma

Novel kinase inhibitor shows promise for the treatment of HCC

Valneva releases data from phase II study of prophylactic C. difficile vaccine candidate

Phase III results for MD-1003 in MS patients with chronic visual loss following optic neuritis

Almirall to acquire dermatology specialist Poli Group

Puma Biotechnology reports plans for neratinib MAA filing

Roche licenses Proximagen VAP-1 inhibitor for inflammatory disease

Baxalta's Adynovate launched for the treatment of hemophilia in adult patients

Mallinckrodt closes sale of CMDS business to Guerbet

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...